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122 The Journal of Thoracic and Cardbjective: This study was undertaken to determine the impact of specific intensive
are procedures on preoperative hemodynamics, incidence of preoperative organ
ysfunction, and in-hospital mortality among neonates with hypoplastic left heart
yndrome with pulmonary overcirculation and to assess the influence of the change
n preoperative management on early postoperative outcome.
ethods: In this retrospective evaluation of 72 neonates with classic hypoplastic left
eart syndrome and severe pulmonary overcirculation with different preoperative
anagement strategies from 1992 to 1995 and from 1996 to 2000, univariate and
ultivariate analyses of risk factors were performed with stepwise logistic regres-
ion.
esults: Among patients with ventilatory and inotropic support from admission
ntil surgery, degree of metabolic acidosis (lowest recorded and prerepair pH
alues) was significantly higher than among patients who received systemic
asodilators without ventilation before surgery. Preoperative organ dysfunction
ccurred in 19 of 72 patients (26%), predominantly before 1996; the most
ignificant was hepatic failure in 13 (68%). Lowest recorded and prerepair pH
alues did not predict the development of organ dysfunction, whereas inotropic
edication, lack of afterload reduction, and especially ventilatory support
orrelated significantly with organ injury. In-hospital mortality decreased from
5% (13/20) to 13% (6/46) from the first to the second period. According to
ultivariate analysis, ventilatory support and organ dysfunction were signifi-
antly related to in-hospital mortality.
onclusion: In neonates with hypoplastic left heart syndrome, systemic afterload
eduction can avoid preoperative artificial respiration, identified as a significant risk
actor for the development of preoperative dysfunction of end organs and in-hospital
ortality.
ince the first report of Norwood and coworkers1 about the staged recon-
structive surgery for hypoplastic left heart syndrome (HLHS), modifica-
tions and refinements in surgical technique and postoperative care have
lowly improved in-hospital survival after the first stage of surgical palliation
rom low figures to a range from 68% to 93%.2-4 Mortality seemed mainly
elated to surgical or postoperative risk factors, with only a few aspects con-
erning the preoperative period considered in the literature. Among these, severe
reoperative metabolic acidosis and lack of prenatal diagnosis were identified as
isk factors for an adverse outcome.5-8 Metabolic acidosis reflects an excessive
iovascular Surgery ● May 2006
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Daldistribution of cardiac output, with significant pref-
rence of the pulmonary blood flow and concomitant
ritical reduction of systemic flow, possibly contributing
o severe end-organ damage (eg, liver injury) or right
entricular dysfunction.6,9-12
Only a few authors have issued some details of their
reoperative management,13,14 and we are unaware of
ny systematic analysis of the influence of various treat-
ent options on patient condition at the time of surgery
nd on postoperative outcome.15-17 Therefore the aim of
ur study in infants with HLHS and pulmonary hyper-
erfusion was to assess the impact of some specific
ntensive care procedures (mechanical ventilation, vaso-
ctive substances) on the incidence of preoperative organ
ysfunction and hospital mortality and to determine
hether our experience with a modification of preopera-
ive management contributed to an improved early post-
perative outcome.
atients and Methods
atients
e reviewed the cases of 126 consecutive infants who were
dmitted for stage I reconstruction for all forms of HLHS from
eptember 1992 to July 2000. In this study, we enrolled only
eonates with classic HLHS (aortic and mitral atresia or steno-
is, diminutive ascending aorta, and severe hypoplasia of the
eft ventricle) with pulmonary hyperperfusion, as determined by
ratio of pulmonary perfusion (Q˙ p) to systemic perfusion (Q˙ s)
reater than 2. Nine infants had no pulmonary overcirculation
Q˙ p/Qs 2) because of restrictive atrial communications, total
nomalous pulmonary venous drainage, and left-sided hypopla-
ia of the pulmonary veins. Patients with other forms of func-
ionally univentricular heart (n  13), significant coarctation
nd thus reduced reverse flow to the coronary arteries (n  4),
r incomplete hemodynamic data (n  16), and infants enrolled
n another study protocol (n  9) were excluded. Finally, 3
atients with major noncardiac congenital defects or severe
rematurity were not enrolled.
Among the remaining 72 infants (49 male and 23 female), two
roups were distinguished according to the period of treatment: 23
atients were treated between 1992 and 1995, representing our
arly experience, and 49 patients were treated between 1996 and
000. All but 6 neonates with severe hepatic or renal damage or
everely depressed myocardial function underwent Norwood op-
ration and comprise the surgical cohort (n  66). The groups did
ot differ with respect to anatomic subgroups of HLHS (mitral
tresia with aortic atresia; mitral stenosis with aortic atresia; mitral
Abbreviations and Acronyms
HLHS hypoplastic left heart syndrome
Q˙ p  pulmonary perfusion
Q˙ s  systemic perfusiontenosis with aortic stenosis; mitral atresia with aortic stenosis e
The Journal of Thoracicnd ventricular septal defect) and birth weight (3363  352 g vs
323  629g), and surgery was performed at a similar median age
8 days vs 6 days), although with a wider range in the first group
3-80 days vs 1-37 days).
So that we could better understand the effect of preoperative
entilation on the degree of metabolic acidosis and pulmonary
vercirculation, we formed three subgroups (Table E1). Nine-
een patients (subgroup 1) received ventilatory support before
r soon after admission until operation, with inotropes and
asodilators as needed. Subgroup 2 included 13 patients who
eceived ventilation for reasons of transport security for less
han 24 hours; most were subsequently treated with sodium
itroprusside for systemic vasodilation. Subgroup 3 included 40
atients who received systemic afterload reduction from the
ime of diagnosis or admission but without mechanical venti-
ation at any time before surgery.
reoperative Evaluation
Ratio of pulmonary to systemic blood flow. Soon after ad-
ission, arterial and central venous lines were placed for pres-
ure and blood gas monitoring, allowing calculations of Q˙ p/Qs
y the Fick equation.18 In patients with HLHS physiology,
ortic and pulmonary arterial saturations are identical. Pulmo-
ary vein oxygen saturation was assumed to be 100% in patients
eceiving mechanical ventilation with an inspired oxygen frac-
ion of 30% or greater (n  5) and to be 95% in patients with
r without ventilation with an inspired oxygen fraction less than
0% (n  27). Q˙ p/Qs greater than 2 was considered to indicate
ulmonary overcirculation.
Right ventricular dysfunction. Right ventricular function was
valuated by 2-dimensional echocardiography after admission and
he day before surgery. We formed two functional categories: (1)
ormal if the function was considered normal or mildly depressed
nd (2) abnormal if it was moderately or severely depressed.
imilarly, the degree of tricuspid regurgitation was classified as
bsent if it was either absent or mild and present if it was moderate
r severe. Because both echocardiograms were evaluated before
he operation, the interpreting cardiologist was blinded to the final
utcome.
Organ dysfunction. Organ dysfunction was considered to be
vident according to the following criteria. Severe hepatic dys-
unction was indicated by high hepatic enzyme levels (aspartate
minotransferase 200 U/L, lactate dehydrogenase 1500 U/L),
educed concentrations of coagulation factors (factors II and V
30%), and increased conjugated bilirubin (0.5 mg/dL). In the
ase of lethal outcome, histologic examination of a liver specimen
as performed with parental consent. Severe renal injury was
ndicated by serum creatinine greater than 200 mol/L. Necrotiz-
ng enterocolitis and seizures were included in the diagnosis of
rgan dysfunction.
reoperative Management
etween 1992 and 1995, mechanical ventilation was considered
he most useful tool to support the neonate with cardiorespiratory
xhaustion. We tried to perform a slight hypoventilation to obtain
permissive hypercapnea (tidal volume 8-10 mL/kg, positivend-expiratory pressure level 3-5 mm Hg, targeted arterial PCO2
and Cardiovascular Surgery ● Volume 131, Number 5 1123
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CH
D5-50 mm Hg) and used continuous sedation with fentanyl and
idazolam to avoid the hyperventilation often triggered by meta-
olic acidosis. As a consequence of the lack of endogenous cat-
cholamines, inotropic support (epinephrine 0.06  0.02 g/[kg/
in], dopamine 3.8  0.9 g/[kg/min]) was necessary in most
ases to compensate for low blood pressures. Supplemental carbon
ioxide and subatmospheric oxygen were not applied. All patients
ere treated with prostaglandin E1 (0.017 g/[kg/min]). Parenteral
utrition was most common, because oral or gastric tube feeding
eemed unfavorable.
Since 1996, we have pursued a new preoperative treatment
rotocol designed to achieve a more favorable ratio between
ystemic and pulmonary vascular resistances. Mainly it is started
n the referring hospital. Whenever feasible, no inotropic or ven-
ilatory support is applied, and patients are extubated as soon as
ossible after admission. Afterload reduction is obtained by con-
inuous infusion of sodium nitroprusside (2.1  0.8 g/[kg/min])
itrated clinically to achieve adequate urinary output and stable
onacidotic blood gas values. Prostaglandin E1 is administered at
reduced dosage (0.005 g/[kg/min]). Oral sedatives are given if
ecessary. Oral or gastric tube feeding until surgery has been
ossible for almost all patients.
urgical and Postoperative Management
he first stage of the reconstructive procedure for HLHS is essen-
ially as previously described.15,17 A 3.0-, 3.5- or 4.0-mm IMPRA
hunt (C. R. Bard, Inc, Murray Hill, NJ) was placed between the
ight subclavian artery and the proximal right pulmonary artery.
uring the study period, there were no significant changes in
ircuit design and conduct of cardiopulmonary bypass. The post-
perative management with mechanical ventilation (tidal volume
8-10 mL/kg, arterial PCO2 35-50 mm Hg), inotropic support
epinephrine, dopamine), and afterload reduction (nitroprusside)
id not change essentially during the study periods.
ata Collection and Analysis
atient data were compiled by reviewing medical files, opera-
ive reports, and echocardiographic results. Data are presented
s mean  SD or median and range as appropriate. The analysis
as conducted both for the time groups and for the therapeutic
ubgroups.1-3
Preoperative factors (prenatal diagnosis, lowest recorded and
rerepair arterial pH values, presence of ventricular dysfunction or
ricuspid insufficiency), preoperative treatment (mechanical venti-
ation, use of vasodilators and inotropic support), and surgical data
r factors (age at operation, era of operation 1992-1995 vs 1996-
000, diameter of ascending aorta, shunt size normalized as cross-
ectional area divided by patient body weight, duration of deep
ypothermic circulatory arrest) were evaluated for impact on per-
isting organ dysfunction at the time of surgery and for the prob-
bility of in-hospital death (Table E2).
Continuous variables were dichotomized at either the me-
ian (age, prerepair pH, normalized shunt size, deep hypother-
ic circulatory arrest duration) or the 10th percentile (lowest
ecorded pH) to create categoric variables. The relevances of
otential risk factors were determined with 2 or Fisher exact
ests. Variables found to be significant by univariate analysis F
124 The Journal of Thoracic and Cardiovascular Surgery ● Maere entered into multivariate analysis with stepwise logistic
egression. Odds ratios are presented with 95% confidence
ntervals. For situations in which the 95% confidence interval
oes not contain the value 1, the corresponding test for odds
atio 1 is significant to the 5% level. The Cochran-Armitage
rend test, which is specifically designed to analyze trends with
ime, was used to determine whether there was a linear trend in
n-hospital mortality year by year. This test should rule out a
ajor influence of the effect of continuously increasing human
xperience.
The Kruskal-Wallis H test was used to confirm the same
istribution of anatomic subtypes of HLHS within the two expe-
ience periods. For comparison between time groups or among
herapeutic subgroups, the nonparametric t test or Wilcoxon rank
est was applied. Statistical analysis was performed with Systat 10
oftware (SPSS Inc, Chicago, Ill).
esults
rgan Dysfunction
reoperative organ dysfunction occurred in 10 of 23 pa-
ients (43%) between 1992 and 1995 and in 9 of 49 (18%)
etween 1996 and 2000. Only 1 case of organ dysfunction
4%) was observed among the last 15 patients, when the
ew treatment protocol was routinely applied immediately
fter diagnosis in the referring hospitals. Fourteen of the 19
ffected patients showed signs of organ dysfunction at
dmission.
Among the 19 patients with organ dysfunction (Table
3), circulatory shock resulted in hepatic failure in 13
68%). Seven of these 13 patients (54%) showed some
mprovement in hepatic function test results and under-
ent cardiac surgery, whereas 6 (3 in each group) had
rreversible hepatic failure and died without operation.
he postmortem analysis of 4 liver specimens revealed
idespread centrilobular necrosis and congestion caused
y microthrombi in the small liver veins. Three of the 7
atients who underwent surgery died of excessive non-
urgical bleeding in the early postoperative period. Be-
ause their coagulation factor II and V levels were still
ignificantly decreased immediately before the operation,
he bleeding may have been related to an inappropriate
ostoperative synthesis of these factors. All patients with
epatic failure also had reduced renal function. Five of
he 19 patients with organ dysfunction (26%) had necro-
izing enterocolitis develop; 3 required bowel resection
efore cardiac surgery. Preoperative seizures were ob-
erved in 1 infant (5%).
The risk factors for preoperative organ dysfunction are
hown in Table 1. Preoperative ventilatory support, inotro-
ic medication, and lack of systemic vasodilation were corre-
ated significantly with organ injury. Ventilatory support
as used in 18 of the 19 infants who had organ injury,
notropic medication in 15, and no afterload reduction in 6.
or the other risk factors, especially the lowest recorded
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DH, no significant association with preoperative organ dys-
unction was seen.
reoperative Management in Subgroups
he influence of the type of preoperative management
subgroups 1-3) on the arterial pH (lowest and immediate
reoperative pH values) is illustrated in Figure 1. All
atients with ventilatory support on admission (sub-
roups 1 and 2) showed a significantly higher degree of
etabolic acidosis than did patients who did not receive
entilatory support at any time before surgery (lowest
ecorded pH 7.08  0.22, P  .0024, and 7.24  0.13, P
.048, vs 7.34  0.06). At the time of surgery, the
rterial pH was significantly lower in patients still receiv-
ng ventilatory support (subgroup 1) than in patients with
xclusive vasodilator therapy (subgroup 3, 7.38  0.08
s 7.45  0.07, P  .023). Five of 19 patients who had
entilation until surgery required an emergency stage I
peration within 48 hours because of unstable hemody-
amics and persistent metabolic acidosis.
n-Hospital Mortality
ixty-six of 72 patients underwent first-stage surgery,
ith an in-hospital mortality of 28.8%. Thirteen of 20
nfants operated on between 1992 and 1995 (65%) died,
hereas only 6 of 46 patients operated on since 1996
13%) died. Statistical analysis specifically designed to
nalyze trends with time showed no significant trend in
n-hospital mortality in either time period; however, a
ery strong time effect was seen when both periods were
nalyzed together.
Preoperative factors. Preoperative factors that corre-
ABLE 1. Univariate risk factor analysis: Preoperative
rgan dysfunction
Risk factor
Odds
ratio
95% Confidence
interval
bsence of prenatal diagnosis 2.3 0.7-8.9
ge at admission (median) 1.6 0.3-7.9
owest recorded plasma pH
(10th percentile)
1.9 0.1-4.4
o systemic vasodilation 5.7 2.3-10.5
entilatory support 14.5* 2.3-154.5
notropic support 6.4 1.8-23.8
rerepair plasma pH (median) 2.4 0.1-4.9
reoperative Q˙p/Qs (median) 2.1 0.4-4.7
umber of patients with organ dysfunction, 19; number without, 53. All
onfidence intervals that do not include the value 1 indicate significant
esults. Variables found to be significant by univariate analysis were
ntered into multivariate analysis with stepwise logistic regression. *Sig-
ificant by multivariate analysis (P  .05).ated significantly with adverse outcome included absence m
The Journal of Thoracicf prenatal diagnosis of HLHS and the lowest preopera-
ively recorded pH, as well as low pH immediately before
urgery (Table 2). Patients with end-organ dysfunction and
lso with right ventricular dysfunction were less likely to
urvive than patients without any organ damage. Among
herapeutic features, ventilatory and inotropic support at any
ime before surgery and lack of systemic vasodilation were
ssociated with significantly increased mortality. In the
ultivariate analysis, ventilatory support and preoperative
rgan dysfunction were significantly related to in-hospital
ortality. In-hospital survival was 89% among patients
ithout mechanical ventilation at any time before surgery
subgroup 3) and differed significantly from that among
atients supported by mechanical ventilation, independent
f time of application of ventilation (subgroup 1, 26% [P 
.007], and subgroup 2, 72% [P  0.032]).
Additional surgical risk factors. Some potential surgi-
al risk factors in this analysis, such as presence of aortic
tresia, diameter of the ascending aorta, and shunt size,
ere not significantly related to in-hospital mortality. Era of
peration and duration of deep hypothermic circulatory
rrest were associated with significantly increased mortality
Table 2).
Comparison of periods. Postoperative mortality between
993 and 1995 (13/20, 65%) was caused by excessive shunt
ow (n  4), bleeding complications (n  3), and right
entricular dysfunction (n  3). Another 2 patients died of
ABLE 2. Univariate risk factor analysis: In-hospital mortality
Risk factor
Odds
ratio
95% Confidence
interval
bsence of prenatal diagnosis 10.5 1.8-17.9
owest recorded plasma pH (10th
percentile)
3.2 1.1-14.1
entilatory support 9.7* 2.9-23.6
o systemic vasodilation 5.6 1.2-9.6
notropic support 8.1 2.3-27.7
rerepair plasma pH (median) 8.3 1.8-15.2
resence of aortic atresia 0.6 0.3-1.7
iameter of ascending aorta (median) 1.6 0.3-1.8
entricular dysfunction 14.6 3.9-54.4
ricuspid insufficiency 1.9 0.6-6.1
ge at operation (median) 2.4 0.8-7.7
rgan dysfunction 11.8* 1.9-19.3
eep hypothermic circulatory arrest
time (median)
4.4 3.8-5.9
ra of operation 6.5 1.1-9.9
hunt size (indexed) 1.5 0.3-1.8
umber of in-hospital deaths, 19; number of survivors, 47. All confidence
ntervals that do not include the value 1 indicate significant results.
ariables found to be significant by univariate analysis were entered into
ultivariate analysis with stepwise logistic regression. *Significant by
ultivariate analysis (P  .05).
and Cardiovascular Surgery ● Volume 131, Number 5 1125
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CH
Devere hepatic fibrosis and failure, and 1 patient died after
arly balloon dilatation of severe coarctation.
Among the 6 in-hospital deaths since 1996, right ven-
ricular dysfunction, which made weaning from cardiopul-
onary bypass impossible, was the most prevalent cause
n  3). Other reasons were the severe obstruction of the
nastomosis between native aorta and pulmonary trunk
n  1), excessive shunt flow (n  1), and intracranial
leeding (n 1). Preexisting organ damage was not a cause
f death during this period.
iscussion
espite improvements in surgical techniques and post-
perative care, the first stage of reconstructive palliation
f HLHS remains at substantial risk for adverse outcome.
isk factor analysis conducted to evaluate the early stage
mortality have proposed various controversial
auses.5,6,9,15,19
The reasons for mortality are multifactorial, and the
otential risk factors are likely to be different for each
ospital caring for patients with HLHS. In previous stud-
es, anatomic and surgical factors, as well as the hazard-
us toxic effect of metabolic acidosis, were discussed.
he degree of metabolic acidosis in parallel circuits
eflects the extent of pulmonary overcirculation burden-
ng a critically diminished systemic perfusion. For that
eason, it seems important to analyze factors contributing
o that hemodynamic imbalance, such as some specific h
126 The Journal of Thoracic and Cardiovascular Surgery ● Maherapeutic features of neonatal medicine often started in
bsence of a definite diagnosis of HLHS. Although the
rerequisite for improved preoperative care is higher
wareness and more rapid diagnosis, simple and appro-
riate guidelines for the primary management of the baby
ith HLHS by referring pediatricians are at least simi-
arly or even more important.
In our cohort, as in those of other centers,6,20 the
ncreased in-hospital mortality among patients without
renatal diagnosis emphasizes the importance of know-
ng about the cardiac diagnosis for establishing appropri-
te early postnatal medical management. Especially in
eonates without a prenatal diagnosis of HLHS, artificial
espiration is used to improve hemodynamic condition. In
ur cohort of patients, however, artificial respiration
roved a significant risk factor for both the development
f organ dysfunction and in-hospital mortality according
o multifactorial analysis. The most likely explanation is
he negative impact of ventilation on pulmonary hyper-
erfusion as a result of the recruitment of previously
onventilated and consequently poorly perfused lung ar-
as. The systemic consequences are prolonged periods of
etabolic acidosis with preoperatively still lower pH
alues in patients receiving ventilatory assistance, inde-
endent of such other therapeutic components as inotro-
ic medication and afterload reduction, resulting in se-
ere organ dysfunction, specifically often irreversible
Figure 1. Lowest recorded (L)
and immediate (I) preoperative
arterial pH values according to
type of preoperative manage-
ment. Columns and error bars
represent mean and upper and
lower SDs, respectively. Aster-
isk indicates significant differ-
ence (P < .05) versus corre-
sponding values of group 3.
Median is for entire cohort.epatic injury (Table 1). Tweddell and colleagues14 iden-
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Dified preoperative mechanical ventilation as the only risk
actor for death until 6 months after stage I palliation.
lthough avoidance of preoperative mechanical ventila-
ion was recommended in a review of Pearl and associ-
tes,21 only our study has specifically evaluated the effect
f ventilatory support on preoperative organ dysfunction
nd overall outcome in infants with HLHS. However, we
id not use inspired gas mixtures that added nitrogen or
arbon dioxide. Tabbutt and colleagues22 evaluated the
mpacts of hypoxia and hypercarbia in a randomized
hort-term (10 minutes) crossover trial and recommended
ypercarbia because of the increased oxygen delivery for
nfants with HLHS with severe hemodynamic deteriora-
ion. However, they pointed out that the majority of
reoperative infants do not require controlled ventilation
efore operation and recommended further studies to
etermine the role for inspired gases. To date, no expe-
ience with longer use of either ventilation strategy until
urgery has been published.
Because many of the patients receiving ventilatory
upport were sedated so that they would tolerate low-tidal
olume ventilation, inotropic support with epinephrine
nd dopamine was given to increase low blood pressures.
ven though only univariate, not multivariate, risk factor
nalysis showed an impact of inotropic support on in-
ospital mortality, it seems likely that it increased sys-
emic afterload and facilitated pulmonary hyperperfu-
ion, which had already been stimulated by artificial
espiration. Other groups who have used preoperative
echanical ventilation in most of their cases have re-
orted the need for inotropic support by approximately
alf of their patients.4 However, they did not see a
ignificant influence of preoperative inotropic support on
urvival after the Norwood operation.
Afterload reduction with nitroprusside was the key-
tone in the treatment of 40 patients without ventilatory
upport during our second observational period. Despite
igh estimates of Q˙ p/Qs after referral, the hemodynamic
urden was well tolerated, with no persistent metabolic
cidosis or organ injury. In most of our patients, pulmo-
ary overcirculation was still present at the time of sur-
ery; however, improved systemic circulation was re-
ected by an alkaline shift in arterial pH. The therapeutic
oncept is that lowering systemic vascular resistance
llows a gradual increase in systemic blood flow while
voiding any active increase in pulmonary blood flow
eg, artificial respiration). For intensive care after the
orwood operation, the same concept of afterload reduc-
ion by phenoxybenzamine to improve systemic oxygen
elivery was introduced by Tweddell and coworkers23 in
999. Hoffman and colleagues24 from the same institu-
ion recently reported a lower arteriovenous oxygen con-
ent difference across the whole oxygen saturation scale f
The Journal of Thoracicfter the Norwood operation in patients treated with
henoxybenzamine than in control patients. The principle
f pharmacologic control of systemic vascular resistance
s obviously working in the preoperative setting. It is
ossible that only its use allowed avoidance of preoper-
tive artificial respiration. Instead of nitroprusside or
-blockers, phosphodiesterase inhibitors such as milri-
one, with inotropic as well as potent afterload-reducing
ction, may be useful drugs, especially for patients with
oor ventricular function or functional tricuspid
nsufficiency.
In our study, preoperative development of organ dys-
unction was identified as an independent significant risk
actor for in-hospital mortality. Jonas and associates6 and
woretzky and coworkers7 have already mentioned this
roblem but did not systematically study either the po-
ential reasons or the prevention of organ dysfunction.
ccording to our data, organ dysfunction was likely caused
r at least facilitated by the hemodynamic consequences of
rtificial respiration, inotropic support, and lack of afterload
eduction.
Although preoperative enterocolitis, transient renal
nd hepatic dysfunction, and seizures did not consider-
bly influence in-hospital mortality after the Norwood
rocedure in some reports,9,25 hepatic injury was the
ost prevalent cause of overall mortality of our early
eries. Hepatic involvement was the most frequent cause
f organ dysfunction, which proved a significant risk
actor for in-hospital mortality even by multivariate anal-
sis. In accordance with Jonas and associates6 and
oodie and colleagues12 but in contrast to Kern and
oworkers,9 we observed several cases of severe hepatic
amage with irreversible collapse of coagulation factor
ynthesis strictly associated with severe preoperative
etabolic acidosis. In addition, if hepatic dysfunction
as not completely alleviated at the time of surgery,
ife-threatening bleeding complications or postoperative
epatic failure occurred. The histologic examination of 4
iver specimens revealed widespread centrilobular liver
ecrosis, substantiating the severity of underlying organ
amage. Thus only patients with complete recovery of
iver function, characterized by normalization of previ-
usly elevated transaminase values, intact synthesis of
oagulation factors, and bilirubin conjugation, are suit-
ble candidates for the Norwood procedure.
imitations of the Study
ur results are based on the retrospective analysis of two
eriods with different preoperative management strate-
ies in our institution between 1993 and 2000, and there-
ore the different therapeutic interventions were not ran-
omized or blinded. The focus was directed toward
actors of preoperative management likely to contribute
and Cardiovascular Surgery ● Volume 131, Number 5 1127
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CH
Do end-organ dysfunction and its influence on overall
utcome. However, it cannot be completely ruled out that
ifferent surgical factors more specific than shortening of
ardiac arrest time, which was significant by univariate
ut not multivariate statistical analysis of in-hospital
ortality, or other than the unchanged postoperative
trategies of pharmacologic and ventilatory support may
lso be responsible for the changed outcome. The con-
inuously increasing and difficult to measure human ex-
erience, Marc deLeval’s “human factor,”26 may have
ad an effect; however we argue that this factor is rather
nlikely to be responsible, because we could demonstrate
o linear yearly trend of decrease in in-hospital mortality
ithin both periods but found uniform percentages of
ospital mortality each year. Analysis with the Cochran-
rmitage trend test, which is specifically designed to
nalyze trends with time, indicates that it is very unlikely
hat the changes result from continuously improving sur-
ical or postoperative management experience. In addi-
ion, if the surgical experience had an effect of major
mportance in lowering in-hospital mortality, the short-
ned cardiac arrest time probably would have shown
tatistical significance by multivariate analysis; however,
his was not the case. The trend toward the use of smaller
odified Blalock-Taussig shunts (3.5 mm instead of 4
m), which probably has influenced the ease of the
ostoperative course, also had no significant effect on
n-hospital mortality.
onclusions
his study of preoperative management of neonates with
LHS showed a significant improvement in outcome as a
onsequence of systemic afterload reduction with vasodilat-
ng agents. This already accepted postoperative therapeutic
rinciple of vasodilator therapy has a positive effect on the
alance of systemic and pulmonary blood flows and may
ave helped to avoid preoperative artificial respiration, a
ignificant risk factor for preoperative dysfunction of end
rgans and in-hospital mortality. Both changes not only
ake intensive care for most neonates with HLHS much
asier but are likely to have a positive effect on overall
utcome.
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DVentricular Dysfunction
t the time of admission severe right ventricular dysfunction was
bserved in 5 of 19 neonates with organ dysfunction (26%) but
nly 2 of 53 without organ dysfunction (4%). Immediately before
urgery, severe ventricular dysfunction was still present in 6 of
hese 7 patients. Because it was not the aim of this study to
nvestigate specific reasons for preoperative right ventricular dys-
unction, no further analysis of contributing factors was per-
ormed.
E In our series, ventricular dysfunction represented the next
ABLE E1. Frequency table of type of preoperative treatme
Subgroup
(n  19)
Ventilation alone 6
Inotropes* 9
Vasodilation* 0
Vasodilation and inotropes* 4
ubgroup 1, Ventilatory support plus inotropes and vasodilators before or s
f transport security and lasting less than 24 hours, plus inotropes, vasod
nd regular systemic afterload reduction. *Treatment in addition to ventil
ABLE E2. Frequencies of risk factors among neonates w
Risk factor
Absence of prenatal diagnosis
Age on admission (median)
Lowest recorded pH (10th percentile)
Ventilatory support
No systemic vasodilation
Inotropic support
Prerepair pH (median)
Presence of aortic atresia
Diameter of ascending aorta (median)
Ventricular dysfunction
Tricuspid insufficiency
Age at operation (median)
Organ dysfunction
Deep hypothermic cardiac arrest time (median)
Shunt size (indexed, mm2)
ABLE E3. Preoperative laboratory results of patients with
f organ injury
No.
Aspartate
aminotransferase
(U/L)
dehy
rgan injury 19 271 198* 226
epatic injury and no surgery† 6 475 142* 273
epatic injury with surgery 7 292 93* 195
o organ injury 53 34.9 25.6 68
rgan injury (n 19) included hepatic and renal injury (n 13), necrotizing
or aspartate aminotransferase and lactate dehydrogenase; immediate preo
. *Significant difference from patients without organ injury. †In group wost frequent preoperative organ disease after liver injury. The p
129.e1 The Journal of Thoracic and Cardiovascular Surgery ● Mrequent coincidence of preoperative right ventricular dysfunction
nd hepatic failure may point to a common harmful etiology, most
ikely circulatory shock and its metabolic consequences.
woretzky and coworkers7 reported a higher occurrence of ven-
ricular dysfunction and tricuspid regurgitation among patients
ith postnatally diagnosed HLHS than among those with a pre-
atal diagnosis. Lloyd and colleagues11 suggested that postnatally
cquired ventricular dysfunction could have been avoided by early
ppropriate management. In our experience, consequent afterload
eduction with nitroprusside increases systemic cardiac output and
Subgroup 2
(n  13)
Subgroup 3
(n  40)
3 0
0 0
8 40
2 0
fter admission until operation; Subgroup 2, ventilatory support for reasons
s, or both; Subgroup 3, no ventilatory support at any time before surgery
support in subgroups 1 and 2.
LHS
1992-1995
(n  23)
1996-2000
(n  49)
17 31
7 26
5 4
21 11
17 1
13 2
16 23
13 29
7 23
4 3
9 12
9 21
10 9
9 26
13.26 12.84
without organ injury, with hepatic dysfunction as subset
e
nase
Conjugated
bilirubin
(mol/L)
Factor II
(%)
Factor V
(%)
Creatinine
(mol/L)
885* 8.6 8.6* 37.5 20.2* 42.6 27.5 175  30*
703* 18.8 8.6* 23.2 4.7* 24.9 5.2* 199  34*
451* 5.1 1.8* 27 5.2* 34.4 7.1* 167  26
341 0 58.3 13.6 66.1 12.4 148  21
rocolitis (n 5), and preoperative seizures (n 1). Worst values recorded
ive recorded values recorded for conjugated bilirubin, factor II, and factor
surgery, values recorded at time of decision against surgery.nt
1
oon a
ilatorith Hand
Lactat
droge
(U/L)
1
2
6
9
ente
peratrevents ventricular dysfunction. In contrast, respiratory and ino-
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Stieh et al Surgery for Congenital Heart Diseaseropic support are more likely to prevent recovery of ventricular
unction, because they contribute to sustained pulmonary overcir-
ulation with consecutive right ventricular enlargement and poten-
ially harmful reduction of systemic cardiac output, which may
lso influence coronary perfusion. In contrast to previous investi-
ators, significant preoperative tricuspid regurgitation, aortic atre-
ia, diameter of the ascending aorta, and shunt size were not found
o be significant predictors of outcome.5
E To find parameters that describe the preoperative hemodynamic
eterioration and may have prognostic value, we examined the lowest
reoperatively recorded and prerepair pH values, neither of which
as correlated significantly with the development of preoperative
rgan dysfunction but both of which were correlated with in-
ospital mortality, as already described by Jonas and associates.6
lthough these values are clinically useful, a specific cutpointannot be given. Laboratory parameters documenting complete d
The Journal of Thoracic anreoperative recovery from organ dysfunction, especially of the
iver, are much more important in this regard.
E Because the retrospective type of the study, we were not able
o describe right ventricular dysfunction by quantitative measures,
uch as fractional area change or myocardial performance index.
s in previous studies,14 we had to use qualitative judgements.
We are aware of the poor reliability of some values such as the
owest recorded pH, often taken from a capillary gas sample in the
eferring hospital, or the Q˙ p/Qs calculations. The systemic venous
aturations were often not very consistent, the pulmonary venous
aturation was not measured but only assumed according to ven-
ilatory status, and the mixed venous saturation may vary depend-
ng on the precise site of the tip of the central venous line.
owever, even if the lowest recorded pH was likely overestimated,
here was no predictive value concerning the development of organ
ysfunction.
d Cardiovascular Surgery ● Volume 131, Number 5 1129.e2
CH
D
